800,000 dengue vaccine recipients analyzed in massive vietnam study
NCT ID NCT07501793
First seen Apr 05, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This study reviews existing records from 800,000 people who received the TAK-003 (Qdenga) dengue vaccine at VNVC centers in Vietnam. Researchers will describe the age, sex, health history, and vaccination patterns of these individuals. No new treatments or direct contact with participants is involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vietnam Vaccine Joint Stock Company
Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam
Conditions
Explore the condition pages connected to this study.